Platelet Transfusion Refractoriness Clinical Trials in Tianjin, Tianjin Municipality
2 recruitingTianjin, Tianjin Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness
Platelet Transfusion Refractoriness
Keymed Biosciences Co.Ltd110 enrolled1 locationNCT06792019
Recruiting
Phase 2
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Severe Aplastic AnemiaPlatelet Transfusion Refractoriness
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT06254560